Drew University releases prostate study
Gay and bisexual African American men have lowest testing rate in state
Los Angeles, CA-Gay and bisexual black men are less likely to be tested for prostate cancer than men of any other racial and ethnic backgrounds regardless of their sexual orientation, according to a recent study by a researcher at Charles Drew University of Medicine and Science. In his study, published in the December issue of Medical Care, Kevin C. Heslin, an assistant professor at Charles Drew University, examined prostate and colorectal testing rates based on sexual orientation, race and ethnicity. Using data from telephone interviews with 19,410 men who participated in the California Health Interview Survey, the research found no overall difference in the use of the prostate-specific antigen (or PSA) test among gay, bisexual and heterosexual men. But the percentage of gay and bisexual black men who received the PSA test was 12% to 14% lower than heterosexual blacks and 15% to 28% lower than gay and bisexual whites. “Gay and bisexual black men had the lowest use of the PSA test, compared with every other group of men in the study,” Heslin said. “For blacks, being a member of both racial and sexual minority groups represents a kind of double jeopardy when it comes to getting PSA testing.” The findings are significant because black men are more likely to be diagnosed late with prostate cancer and, as a result, are more likely to die from the disease than any other racial or ethnic group. Prostate and colorectal cancers are the second and third most common causes of cancer deaths among men in the United States, exceeded only by lung cancer. Overall, the study found that a greater percentage of gay and bisexual men received colorectal cancer tests compared with heterosexual men, which suggests that gay and bisexual men may have better access to preventive screening than heterosexuals. But the researchers point out that the difference may be partly due to the fact that colorectal cancer tests-such as colonoscopy, sigmoidoscopy, and proctoscopy-are also used to diagnose sexual health problems among gay men. All the men in the study were age 50 and over, which is the age at which screening for prostate and colorectal cancer is recommended by many professional organizations. The American Cancer Society guidelines recommend that African American males begin receiving the PSA screening test at age 45. Funded by the National Institutes of Health (NIH), the study, “Sexual Orientation and Testing for Prostate and Colorectal Cancers among Men in California,” suggests that health services planners seeking to address racial and ethnic disparities in prostate cancer may need to consider sexual orientation when developing culturally specific screening programs for high-risk subgroups of men, such as African Americans.
Winston Churchill once said, “to every man there comes a time in his life when he is figuratively tapped on the shoulder and offered a chance to do a great and mighty work; unique to him and fitted to his talents; what a tragedy if that moment finds him unprepared or unqualified for the moment that could be his finest hour.”
LOS ANGELES, Calif. — Scientists from Cedars-Sinai Medical Center and UCLA announced today they have created a new device which could enable doctors to create personalized prostate cancer treatments.
If more studies confirm the technology’s effectiveness, the NanoVelcro Chip would enable doctors to access and identify cancerous cells in the bloodstream, which would provide the diagnostic information needed to create individually tailored treatments, according to Cedars-Sinai.
WASHINGTON, D.C.—The United States Preventive Services Task Force has issued its final recommendation for early detection of prostate cancer, effectively eliminating the PSA test and leaving American men without a defense in the fight against prostate cancer, according to Skip Lockwood, CEO of Zero—The Project to End Prostate Cancer.
The president’s public support of same-sex marriage could either be a boon or a curse for his re-election campaign. It’s too soon to tell, despite the fact that he’s just received a million dollars in campaign contributions. But one thing is certain: the president’s public stance in favor of homosexual marriage has drawn a dividing line among voters. Will it have an effect among African American voters, some members of the clergy think it will.
BOSTON, Mass.—Billionaire Warren Buffet, who is nearly 82 years old, announced that he was diagnosed with prostate cancer.
“I discovered the cancer because my PSA level recently jumped beyond its normal elevation and a biopsy seemed warranted,” Buffet explains. Diagnosed with stage 1 prostate cancer, he has chosen radiation treatment five days a week for six weeks.